Benefit versus toxicity risk of digoxin in patients with COVID-19 | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PostScript

Letter

Benefit versus toxicity risk of digoxin in patients with COVID-19

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

	Abstract	Full	Pdf
Jun 2021	759	758	52
Jul 2021	192	191	23
Aug 2021	97	97	23
Sep 2021	85	84	18
Oct 2021	85	79	32
Nov 2021	124	112	21
Dec 2021	151	147	19
Jan 2022	151	147	18
Feb 2022	103	102	11
Mar 2022	148	146	12
Apr 2022	140	139	7
May 2022	227	228	78
Jun 2022	112	111	11
Jul 2022	108	108	12
Aug 2022	117	114	8
Sep 2022	120	119	11
Oct 2022	369	113	20
Nov 2022	767	12	16
Dec 2022	358	6	8
Jan 2023	174	4	8
Feb 2023	156	3	12
Mar 2023	98	0	9
Apr 2023	193	0	4
May 2023	95	0	5
Jun 2023	61	0	1
Jul 2023	68	1	2
Aug 2023	61	0	4
Sep 2023	48	0	1
Oct 2023	87	0	3
Nov 2023	77	1	2
Dec 2023	102	0	3
Jan 2024	30	0	0
Feb 2024	42	0	1
Mar 2024	44	1	0
Total	5549	2823	455